Announcing the global teams that have been shortlisted for a Cancer Grand Challenges award
Today, we are excited to reveal the 12 shortlisted teams who are in with a chance of securing up to $25m in Cancer Grand Challenges funding to make radical progress against some of cancer’s toughest challenges.
In March 2023, we…
In an ‘In Focus’ commentary article for AACR Cancer Discovery, Dr David Scott and Dr Dinah Singer discuss our nine new Cancer Grand Challenges, for which Expressions of Interest are open until 22 June 2023.
In March at…
Members of the Cancer Grand Challenges PRECISION team have developed a living biobank of 115 patient-derived Mouse-INtraDuctal (MIND) ductal carcinoma in situ (DCIS) models and used them to identify risk factors…
Cancer is the second leading cause of death among children and adolescents worldwide. Yet, despite progress in understanding the biology of many childhood cancers, treatments, particularly for solid tumours, have…
Today we launch Discover: a year of scientific creativity – our annual progress magazine
We are excited to launch our annual progress magazine, Discover: a year of scientific creativity. Discover celebrates how the…
In November 2022, Cancer Grand Challenges held its first in-person Future Leaders Conference in Barcelona, providing an opportunity for early-career researchers worldwide to connect, network and spark new scientific…
Cancer Grand Challenges research covers a broad spectrum of areas and disciplines, with teams generating novel insights at each stage of the research pipeline.
Here, Gemma Balmer-Kemp, head of research at Cancer Grand…
Cancer Grand Challenges awarded grants to four teams –CANCAN, PROMINENT, eDyNAmiC and NexTGen – in its third round of funding in 2022. Charles Swanton, a member of the Cancer Grand Challenges Scientific Committee,…
Lorenzo de la Rica, Research Programme Manager at Cancer Grand Challenges, provides his insights on the importance of the latest paper from the Cancer Grand Challenges eDyNAmiC team, tackling the extrachromosomal DNA…
When it comes to cancer research, we regularly hear good news about the number of people benefiting from advances in treatment. But there is one bad news story about the condition that gets little attention. For three…